Oncotelic Therapeutics Statistics
Total Valuation
OTLC has a market cap or net worth of $12.39 million. The enterprise value is $25.50 million.
Market Cap | 12.39M |
Enterprise Value | 25.50M |
Important Dates
The last earnings date was Thursday, April 13, 2023.
Earnings Date | Apr 13, 2023 |
Ex-Dividend Date | n/a |
Share Statistics
OTLC has 399.68 million shares outstanding. The number of shares has increased by 1.79% in one year.
Shares Outstanding | 399.68M |
Shares Change (YoY) | +1.79% |
Shares Change (QoQ) | +0.05% |
Owned by Insiders (%) | 54.83% |
Owned by Institutions (%) | n/a |
Float | 184.09M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | 4.03 |
PS Ratio | 177.00 |
Forward PS | n/a |
PB Ratio | 1.05 |
P/FCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | 364.23 |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.01, with a Debt / Equity ratio of 1.13.
Current Ratio | 0.01 |
Quick Ratio | 0.01 |
Debt / Equity | 1.13 |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -65.79% and return on invested capital (ROIC) is -26.20%.
Return on Equity (ROE) | -65.79% |
Return on Assets (ROA) | -25.98% |
Return on Capital (ROIC) | -26.20% |
Revenue Per Employee | $3,182 |
Profits Per Employee | -$353,925 |
Employee Count | 22 |
Asset Turnover | 0.00 |
Inventory Turnover | n/a |
Taxes
Income Tax | -6.11M |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +24.00% in the last 52 weeks. The beta is -0.05, so OTLC's price volatility has been lower than the market average.
Beta (5Y) | -0.05 |
52-Week Price Change | +24.00% |
50-Day Moving Average | 0.04 |
200-Day Moving Average | 0.04 |
Relative Strength Index (RSI) | 35.94 |
Average Volume (20 Days) | 60,585 |
Short Selling Information
The latest short interest is 662,753, so 0.17% of the outstanding shares have been sold short.
Short Interest | 662,753 |
Short Previous Month | 812,771 |
Short % of Shares Out | 0.17% |
Short % of Float | 0.36% |
Short Ratio (days to cover) | 8.04 |
Income Statement
In the last 12 months, OTLC had revenue of $70,000 and -$7.79 million in losses. Loss per share was -$0.02.
Revenue | 70,000 |
Gross Profit | 70,000 |
Operating Income | -6.59M |
Pretax Income | -8.08M |
Net Income | -7.79M |
EBITDA | -467,972 |
EBIT | n/a |
Loss Per Share | -$0.02 |
Balance Sheet
The company has $208,989 in cash and $13.31 million in debt, giving a net cash position of -$13.11 million or -$0.03 per share.
Cash & Cash Equivalents | 208,989 |
Total Debt | 13.31M |
Net Cash | -13.11M |
Net Cash Per Share | -$0.03 |
Equity (Book Value) | 11.83M |
Book Value Per Share | 0.03 |
Working Capital | -16.28M |
Cash Flow
Operating Cash Flow | -1.30M |
Capital Expenditures | n/a |
Free Cash Flow | -1.30M |
FCF Per Share | -$0.00 |
Margins
Gross margin is 100.00%, with operating and profit margins of -9,411.58% and -11,123.36%.
Gross Margin | 100.00% |
Operating Margin | -9,411.58% |
Pretax Margin | -11,535.99% |
Profit Margin | -11,123.36% |
EBITDA Margin | -668.53% |
EBIT Margin | n/a |
FCF Margin | -1,859.21% |
Dividends & Yields
OTLC does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -1.79% |
Shareholder Yield | -1.79% |
Earnings Yield | -62.84% |
FCF Yield | -10.50% |
Analyst Forecast
Price Target | n/a |
Price Target Difference | n/a |
Analyst Consensus | n/a |
Analyst Count | n/a |
Revenue Growth Forecast (5Y) | n/a |
EPS Growth Forecast (5Y) | n/a |
Stock Splits
The last stock split was on December 28, 2012. It was a reverse split with a ratio of 1:12.
Last Split Date | Dec 28, 2012 |
Split Type | Reverse |
Split Ratio | 1:12 |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | 2 |